Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Takeda Pharmaceutical Ties Up with US Start-Up in T-Cell Cancer Therapy

Filed Under: Industry, Pharma Tagged With: , , ,

Takeda Pharmaceutical Co. Ltd. (TYO:4502) announced on Jan. 12 that it has entered into an agreement to collaborate with Maverick…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Kyoto University Venture Thyas Uses iPS Cells to Generate Killer T Cells for Cancer Treatment
Kyoto University Venture Thyas Uses iPS Cells to Generate…
Coronavirus Report – Part 77: Japan’s Pharmaceutical Companies Move in Quick Order to Treat Infection
Coronavirus Report – Part 77: Japan’s Pharmaceutical…
AGC in Race to Bolster CDMO Operations Across US, Europe and Japan
AGC in Race to Bolster CDMO Operations Across US, Europe and…
Tokyo Tech Devises a New Generation of BPA for Use in Chemical Surgery
Tokyo Tech Devises a New Generation of BPA for Use in…
Tokyo Institute of Technology, Kanto Chemical Develop Growth Medium for iPS Cell-Derived Small Intestine Models
Tokyo Institute of Technology, Kanto Chemical Develop Growth…
AGC Looks to Advance Into Gene and Cell Therapy Business With Tender Offer for MolMed
AGC Looks to Advance Into Gene and Cell Therapy Business…